← Evidence map

ArticleWiener klinische Wochenschrift2007

Lipoprotein lipase HindIII polymorphism influences HDL-cholesterol levels in statin-treated patients with coronary artery disease.

Martin Javorský et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

this papercites it

Lipoprotein lipase HindIII polymorphism influences HDL-cholesterol levels in statin-treated patients with coronary artery disease. | OpenQuestion